In the cellular fraction of peripheral human blood, MALAT1 as a biomarker of screening NSCLC exhibited low sensitivity of 56% and high specificity of 96%, which demonstrated MALAT1 cannot be an independent but a complementary biomarker to diagnose NSCLC [20]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.